Screener
PTC Therapeutics PTCT Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Liability for sale of future royalties- current | 305,041 | 283,000 |
| Total current liabilities | 923,604 | 968,427 |
| Operating lease liabilities- noncurrent | 90,072 | 93,583 |
| Finance lease liabilities- noncurrent | — | 3,000 |
| Liability for sale of future royalties- noncurrent | 2,022,189 | 2,025,366 |
| Other long-term liabilities | 13,704 | 13,704 |
| Total liabilities | 3,049,569 | 3,104,080 |
| Stockholders’ deficit: |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's finance lease liabilities?
- PTC Therapeutics (PTCT) reported finance lease liabilities of $3M in Q4 2025.
- How has PTC Therapeutics's finance lease liabilities changed year-over-year?
- PTC Therapeutics's finance lease liabilities decreased by 80.7% year-over-year, from $15.57M to $3M.
- What is the long-term trend for PTC Therapeutics's finance lease liabilities?
- Over 5 years (2020 to 2025), PTC Therapeutics's finance lease liabilities has grown at a -33.5% compound annual growth rate (CAGR), from $23.05M to $3M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about PTC Therapeutics's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude